Stemcells, Inc. Announces First High-Dose

Stemcells, Inc. Announces First High-Dose Patient Transplanted in Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration FDA Authorizes Expansion to Five Trial Sites in the United States NEWARK, Calif., Sep 12, 2013  StemCells, Inc. today… read more →